love is the answer
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
PSID on watch alert till october
yes this stock could shoot up at the right PR and other good showings in a real quick manner
if there product goes well at the conf this stock should do well only time will tell here
some NEWS out The ExcitePCR Press Conference will be held from 10-11 a.m. (ET) on Monday, September 18, 2017. if it goes well we should see a nice rise in stock prices
this company has potential to really explode upwards and real soon this should be a watch alert
agreed "The Regulatory Committee is a component of the Institutional Review Board and integral to the protocol approval process to commence the study," commented Dr. Jonathan Head, Chief Executive Officer at OncBioMune. "I interpret the protocol now being in their hands as a signal that we are getting close to conducting the first ever trial of ProscaVax as a front-line treatment for prostate cancer." its now they either make it or break it only time will tell.
I agree its going to be shocking for all of us this thing is ready to burst out wait until October comes
OBMP things are heating up now more news out today
another hidden gem under the radar and with a therapeutic vaccine,ProscaVax – A Novel Prostate Cancer Vaccine It is marketable and would be very profitable upon FDA approval.
we will find out in October when the trial results are exposed to us then we will see if this has the potential to become a great stock
OBMP news out OncBioMune to Present Abstract on Clinical Trial of Novel Prostate Cancer Vaccine at American Association of Cancer Research Special Conference
OBMP news release Final Patient Completes Treatment in OncBioMune Clinical Trial of ProscaVax for Prostate Cancer
NEWS out Final Patient Completes Treatment in OncBioMune Clinical Trial of ProscaVax for Prostate Cancer
BATON ROUGE, LA--(Marketwired - August 24, 2017) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a revenue-stage biopharmaceutical company engaged in the development of targeted cancer therapies, a proprietary cancer vaccine technology and commercialization of a portfolio of products internationally, is pleased to announce that the 20th and final patient in the Phase 1A portion of a Phase 1 trial of ProscaVax for prostate cancer completed treatment per protocol. In the study, ProscaVax, the Company's novel immunotherapeutic cancer vaccine consisting of a combination of tumor-associated prostate specific antigen (PSA) with the biological adjuvants interleukin-2 (IL-2) and granulocyte-macrophage colony-stimulating factor (GM-CSF), is being evaluated for safety, tolerability and efficacy in PSA-progressing prostate cancer in hormone-naïve and hormone-independent patients.
ay
CERC is on fire right now wonder why?
you are correct this play could rise very very fast
didn't you say 10 awhile back lol lets hope for anything but its current price
CERC news out this morning
OPTT on watchlist for thurs
PSID news out today PositiveID Successfully Detects Ebola Virus on its Firefly Dx Prototype System
OBMP news out today Aug 03, 2017 (Marketwired via COMTEX) -- BATON ROUGE, LA--(Marketwired - August 03, 2017) - OncBioMune Pharmaceuticals, Inc. (otcqb:OBMP) ("OncBioMune" or the "Company"), a revenue-stage biopharmaceutical company engaged in the development of targeted cancer therapies, a proprietary cancer vaccine technology and commercialization of a portfolio of products internationally, today announces the submission of an application to Comisión Federal para la Protección contra Riesgos Sanitarios (COFEPRIS), Mexico's equivalent of the U.S. Food and Drug Administration, seeking approval to commercialize an anti-rabies drug licensed from a NASDAQ-listed biopharmaceutical company (the "License Partner
news out OncBioMune Submits Application to Commercialize Anti-Rabies Drug in Mexico
ORPN looking ready to take a run
it will turn around soon just watch and see
yes its time for this play to turn around for the positive lets get er done
we hit a bottom here now its time to head up and send this thing to higher waters need people to know this is a great company and some PR would help the cause im sure
this is a great little company with a big chance to get on the right track and I think it will continue to climb higher here just watch
true but they have some good trial drugs in the works and this thing could explode if it comes out right
Phase 2 Trial of ProscaVax for Early-Stage Prostate Cancer Nears Commencement when the results are released we could see a nice uptick a very nice uptick
SCAM stock alert last reverse split eat the rest of my shares now im out completely which is much ok but will be contacting the investigation going on with this company good bye drys but not for long when they have to make a settlement payment lol
ORPN looking to make a run soon must watch
this could rocket over a dollar in a swift blow got to be ready
looks like we are forming a bottom here
LXRP is worth keeping an eye on now
OPTT powerhour run coming
the run has begun hope you loaded up on your shares we are heading for 3 dollar plus
not worried this stock is getting ready for a run shortly just watch
this stock is on a steady rise its only going to get better now
yup I believe you are correct
ASTI news just released keep watch today
news out this morning keep watch could be a nice day here
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads